Tg(tetO-Pou2af1)1Pjln
Transgene Detail
|
|
| Symbol: |
Tg(tetO-Pou2af1)1Pjln |
| Name: |
transgene insertion 1, Peter J Nielsen |
| MGI ID: |
MGI:2447124 |
| Synonyms: |
tetO-BOB.1/OBF.1 |
| Transgene: |
Tg(tetO-Pou2af1)1Pjln Location: unknown
|
| Alliance: |
Tg(tetO-Pou2af1)1Pjln page
|
|
| Strain of Origin: |
Not Specified
|
|
| Transgene Type: |
|
Transgenic (Inducible, Inserted expressed sequence) |
| Inducer: |
|
doxycycline/tetracycline |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A transgenic construct was generated in which a bidirectional tetracycline operator (tetO) was placed between sequences encoding Pou2af1 and luciferase. Conditional expression of both luciferase and Pou2af1 was demonstrated by the expression of a tetracycline transactivator and administration of doxycycline.
(J:67362)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:67362 Hess J, et al., The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol Cell Biol. 2001 Mar;21(5):1531-9 |
| All: |
4 reference(s) |
|
Analysis Tools
